GAMMA Investing
EWTX icon

GAMMA Investing’s Edgewise Therapeutics EWTX Stock Holding History

GAMMA Investing’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$108K Buy
2,666
+559
+27% +$23.8K ﹤0.01% 1822
2026
Q2 		$85.6K Sell
2,107
-182
-8% -$6.27K ﹤0.01% 1924
2026
Q1 		$72.1K Buy
2,289
+935
+69% +$27K ﹤0.01% 1905
2025
Q4 		$33.6K Buy
1,354
+196
+17% +$3.93K ﹤0.01% 2318
2025
Q3 		$18.8K Sell
1,158
-8
-0.7% -$113 ﹤0.01% 2543
2025
Q2 		$15.3K Sell
1,166
-241
-17% -$3.48K ﹤0.01% 2597
2025
Q1 		$31K Buy
1,407
+86
+7% +$2.26K ﹤0.01% 2138
2024
Q4 		$35.3K Buy
1,321
+33
+3% +$1.05K ﹤0.01% 1932
2024
Q3 		$34.4K Buy
1,288
+101
+9% +$2.01K ﹤0.01% 1754
2024
Q2 		$21.4K Sell
1,187
-19
-2% -$331 ﹤0.01% 1812
2024
Q1 		$22K Buy
1,206
+100
+9% +$1.59K ﹤0.01% 1584
2023
Q4 		$19.7K Buy
+1,106
New +$7.76K 0.01% 1518

Other funds holding EWTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

GAMMA Investing's EWTX Position: Q3 2026 in Review

GAMMA Investing increased its Edgewise Therapeutics (EWTX) stake by 27% in Q3 2026, buying an estimated $23.8K and bringing the position to 2,666 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

GAMMA Investing first reported a position in EWTX in Q4 2023 and has held it in 12 quarters since. 9 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • GAMMA Investing held 2,666 shares of Edgewise Therapeutics worth $108K as of Q3 2026.
  • GAMMA Investing bought 559 Edgewise Therapeutics shares in Q3 2026, an estimated $23.8K.
  • Edgewise Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1822 holding.
  • GAMMA Investing first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • 9 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.